ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 114 filers reported holding ATHIRA PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125,384 | -62.8% | 62,071 | -45.6% | 0.00% | – |
| Q2 2023 | $336,820 | -58.1% | 114,176 | -64.5% | 0.00% | – |
| Q1 2023 | $803,445 | +62.6% | 321,377 | +106.2% | 0.00% | – |
| Q4 2022 | $494,144 | -15.7% | 155,881 | -21.0% | 0.00% | – |
| Q3 2022 | $586,000 | +190.1% | 197,298 | +198.4% | 0.00% | – |
| Q2 2022 | $202,000 | -78.3% | 66,122 | -3.9% | 0.00% | – |
| Q1 2022 | $929,000 | -23.3% | 68,792 | -26.0% | 0.00% | – |
| Q4 2021 | $1,211,000 | -27.8% | 92,919 | -48.0% | 0.00% | – |
| Q3 2021 | $1,677,000 | -40.8% | 178,773 | -35.4% | 0.00% | – |
| Q2 2021 | $2,831,000 | +585.5% | 276,538 | +1132.1% | 0.00% | – |
| Q1 2021 | $413,000 | -30.0% | 22,445 | +30.4% | 0.00% | – |
| Q4 2020 | $590,000 | +2581.8% | 17,215 | +1334.6% | 0.00% | – |
| Q3 2020 | $22,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 714,763 | $2,265,799 | 2.16% |
| Perceptive Advisors | 4,797,278 | $15,207,371 | 0.43% |
| Potomac Capital Management, Inc. | 80,000 | $254 | 0.30% |
| Bristlecone Advisors, LLC | 696,629 | $2,208,314 | 0.27% |
| TANG CAPITAL MANAGEMENT LLC | 485,234 | $1,538,192 | 0.22% |
| RA Capital Management | 1,881,300 | $5,963,721 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 270,989 | $859 | 0.11% |
| PATHSTONE FAMILY OFFICE, LLC | 3,631,080 | $8,182,650 | 0.07% |
| Laird Norton Wetherby Trust Company, LLC | 130,000 | $412,100 | 0.06% |
| Forefront Analytics, LLC | 22,350 | $70,851 | 0.04% |